Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
BABA-W
09988
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -85.37%-1.29M | 64.17%-345.97K | 50.37%-157.78K | 46.38%-2.28M | 56.82%-299.47K | 1.80%-697.73K | 48.95%-965.72K | 66.81%-317.92K | 39.04%-4.25M | 49.71%-693.5K |
| Net income from continuing operations | 45.08%-461.5K | 18.03%-544.35K | 61.45%-519.25K | 32.76%-3.68M | 20.06%-832.8K | 47.51%-840.32K | 51.32%-664.11K | 8.52%-1.35M | 29.20%-5.48M | 34.59%-1.04M |
| Operating gains losses | -123.04%-2.55K | 549.77%103.94K | -49.78%786 | 188.79%22.73K | 86.56%-5.88K | 295.68%11.05K | -32.21%16K | 614.61%1.57K | -489.59%-25.59K | -89.54%-43.76K |
| Depreciation and amortization | --0 | --0 | --0 | 1.49%10.67K | 2.68%2.72K | 1.68%2.66K | 1.87%2.66K | -0.27%2.63K | -10.53%10.51K | 0.30%2.65K |
| Asset impairment expenditure | ---13.57K | --0 | --0 | 63.57%875.34K | -106.01%-6.28K | --0 | --0 | --881.62K | 422.85%535.15K | --104.4K |
| Remuneration paid in stock | --0 | --0 | --0 | ---- | ---- | --0 | ---123.85K | ---162.47K | ---- | ---- |
| Remuneration paid in stock | -96.89%1.3K | -92.88%2.41K | -87.15%8.88K | -35.16%164.85K | -75.83%20.03K | -50.41%41.88K | 114.16%33.84K | -2.87%69.1K | -74.95%254.24K | -44.48%82.85K |
| Other non cashItems | 211.09%8.55K | 154.32%4.81K | 167.15%3.72K | -124,684.21%-307.72K | -11,717.29%-285.62K | -134.19%-7.7K | -2.40%-8.86K | 50.58%-5.54K | 100.63%247 | 89.70%-2.42K |
| Change In working capital | -971.69%-825.6K | 139.40%87.22K | 43.77%348.09K | 41.23%637.49K | 155.23%522.04K | -77.34%94.71K | 64.46%-221.39K | -46.42%242.12K | 239.83%451.39K | 88.49%204.54K |
| -Change in receivables | -716.03%-18.79K | 96.82%-198 | -34.99%26.47K | 156.90%17.32K | 42.87%-20.21K | -77.12%3.05K | 52.20%-6.23K | 774.21%40.71K | -732.61%-30.44K | -321.42%-35.38K |
| -Change in prepaid assets | 99.03%-410 | 58.41%35.85K | -52.27%66.37K | -27.04%226.63K | -46.42%107.41K | -139.09%-42.46K | 115.11%22.63K | -8.10%139.05K | 850.88%310.64K | -14.08%200.47K |
| -Change in payables and accrued expense | -701.25%-806.4K | 121.69%51.57K | 309.31%255.26K | 129.90%393.54K | 1,002.27%434.84K | -54.69%134.12K | 48.33%-237.79K | -78.93%62.36K | 159.80%171.18K | 128.02%39.45K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -85.37%-1.29M | 64.17%-345.97K | 50.37%-157.78K | 46.38%-2.28M | 56.82%-299.47K | 1.80%-697.73K | 48.95%-965.72K | 66.81%-317.92K | 39.04%-4.25M | 49.71%-693.5K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -88.08%1.26K | -89.06%1.27K | -77.52%1.85K | -19.96%32.6K | -56.77%2.25K | -6.33%10.53K | 21.03%11.62K | -44.15%8.21K | 144.26%40.73K | 106.55%5.2K |
| Net PPE purchase and sale | ---- | ---- | ---- | --0 | --0 | --0 | --0 | ---- | 98.72%-1.67K | --0 |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Interest received (cash flow from investment activities) | -88.08%1.26K | -89.06%1.27K | -77.52%1.85K | -23.12%32.6K | -56.77%2.25K | -6.33%10.53K | 3.09%11.62K | -44.15%8.21K | 7.91%42.4K | -77.86%5.2K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -88.08%1.26K | -89.06%1.27K | -77.52%1.85K | -19.96%32.6K | -56.77%2.25K | -6.33%10.53K | 21.03%11.62K | -44.15%8.21K | 144.26%40.73K | 106.55%5.2K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 23,035.56%5.78M | -79.23%294.01K | 207.14K | -54.35%1.59M | -84.28%150.62K | 4,388.16%25K | -44.02%1.42M | 0 | -41.94%3.49M | 3,293.01%957.9K |
| Net issuance payments of debt | ---179.78K | --175K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net common stock issuance | --5.96M | -91.44%119.01K | --207.14K | -60.48%1.38M | -101.35%-12.97K | --0 | -45.00%1.39M | --0 | -41.94%3.49M | 3,293.01%957.9K |
| Proceeds from stock option exercised by employees | --0 | --0 | ---- | --50K | --0 | --25K | --25K | ---- | --0 | --0 |
| Net other financing activities | ---- | ---- | ---- | --163.58K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 23,035.56%5.78M | -79.23%294.01K | --207.14K | -54.35%1.59M | -84.28%150.62K | 4,388.16%25K | -44.02%1.42M | --0 | -41.94%3.49M | 3,293.01%957.9K |
| Net cash flow | ||||||||||
| Beginning cash position | -82.59%170.37K | -56.94%222.46K | -79.25%171.29K | -46.85%825.59K | -43.42%314.88K | -21.63%978.32K | -15.32%516.62K | -46.85%825.59K | -40.02%1.55M | -81.70%556.57K |
| Current changes in cash | 778.31%4.49M | -110.98%-50.69K | 116.53%51.21K | 9.60%-656.99K | -154.26%-146.28K | 5.38%-662.2K | -28.62%461.53K | 67.16%-309.72K | 31.76%-726.75K | 118.12%269.6K |
| Effect of exchange rate changes | 337.93%2.95K | -922.94%-1.4K | -105.91%-44 | 367.10%2.7K | 616.24%3.02K | -115.22%-1.24K | 102.02%170 | 553.66%744 | -103.54%-1.01K | -580.23%-585 |
| End cash Position | 1,381.55%4.67M | -82.59%170.37K | -56.94%222.46K | -79.25%171.29K | -79.25%171.29K | -43.42%314.88K | -21.63%978.32K | -15.32%516.62K | -46.85%825.59K | -46.85%825.59K |
| Free cash from | -85.37%-1.29M | 64.17%-345.97K | 50.37%-157.78K | 46.40%-2.28M | 56.82%-299.47K | 1.80%-697.73K | 48.99%-965.72K | 66.81%-317.92K | 40.13%-4.26M | 53.20%-693.5K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.